UnitedHealth insurance plans will pass rebates to consumers. The insurer is planning to move discounts negotiated by PBMs to patients at the drugstore starting with new employer-sponsored plans in 2020. It would go beyond proposals by the Trump administration to require Medicare plans to pass on rebates by extending discounts to commercial insurance. (CNBC)

The National Cancer Institute’s leader has been appointed as acting FDA commissioner. Ned Sharpless will take over from Scott Gottlieb, who announced his resignation last week, in April. Sharpless has led the National Cancer Institute since October 2017. (MM&M)

Drug prices fell 1% in February, the biggest one-month decline in history. Meanwhile, prescription drug prices fell by 1.2% over the past year, the biggest 12-month decline since 1972, according to the Bureau of Labor Statistics. (MarketWatch)

President Donald Trump’s budget proposal would give more money to the FDA, but would cut science funding at other agencies. The budget has proposed a 12% cut across the entire Department of Health and Human Services, with reductions at the National Institutes of Health and the National Science Foundation. (Endpoints)

Eli Lilly’s combination lung-cancer treatment succeeded in a late-stage study. The treatment combined Lilly’s Cyramza and Roche’s chemotherapy, erlotinib. The trial tested the drugs in patients with metastatic non-small-cell lung cancer. (Reuters)